Multiple Sclerosis Journal · 2015 · 153 citations · 29 references
MedicineNeurologyPediatricsNeuroimmunologyNeuropathologyPediatric NeurologyAntibody CharacterizationDemyelinating DiseasesDemyelinating DisordersPediatric NeuroimmunologyPediatric Neurologic DisordersPediatric NeuropathologyAntibodiesGreen Fluorescent Protein ReportersMog Antibody DiseaseMog Antibody-associated DiseaseMyelin AntigensMyelin-associated GlycoproteinPediatric Demyelinating DisordersPediatric Magnetic Resonance Imaging
OBJECTIVE: To investigate the clinical and magnetic resonance imaging (MRI) features of anti-myelin oligodendrocyte glycoprotein (MOG) antibody-seropositive pediatric demyelinating syndromes. METHODS: Serum samples collected from 74 children with suspected demyelinating disorders whom were being followed at Massachusetts General Hospital were incubated with control green fluorescent protein (GFP)- and MOG-GFP-transfected Jurkat cell clones. The binding ratios were calculated using flow cytometry. Using statistical analyses, we compared the demographic, clinical and radiological features in our seropositive and seronegative patients. RESULTS: We found that 13 out of 74 (17.5%) patients were seropositive for MOG. The MOG-seropositive patients were younger than the seronegative patients (p = 0.049). No single disease category predominated among the seropositive patients, nor was one group more likely to have a polyphasic course. There were two out of four neuromyelitis optica (NMO) patients who had MOG antibodies; both were seronegative for aquaporin -4 (AQP4) antibodies. One had monophasic disease and the other had frequent relapses. There was a bimodal distribution of the MOG-seropositive patients by age at onset, with a distinct younger group (4-8 years) having a high prevalence of encephalopathy and an older group (13-18 years), whom presented almost exclusively with optic neuritis. MRI analysis demonstrated the absence of corpus callosum lesions in the seropositive patients (p = 0.012). The annualized relapse rate (ARR) and the Expanded Disability Status Scale (EDSS) results at 2 years did not differ between the seropositive and seronegative patients. CONCLUSION: MOG antibodies are found across a variety of pediatric demyelinating syndromes having some distinct clinical and MRI features.
29
Revised diagnostic criteria for neuromyelitis optica
Dean M. Wingerchuk, Vanda A. Lennon, Sean J. Pittock et al. · Neurology · 2006 · 2.6K citations · Full text
Medicine, Neurology, Neuropathology +10
Lauren Krupp, Marc Tardieu, Maria Pia Amato et al. · Multiple Sclerosis Journal · 2013 · 1.1K citations
Medicine, Neurology, Pediatrics +15